# Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/atezolizumab-for-first-line-treatment-of-metastatic-nonsquamous-nsclc/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mark A. Socinski,Robert M. Jotte,Federico Cappuzzo,Francesco Orlandi,Daniil Stroyakovskiy,Naoyuki Nogami,Delvys Rodríguez‐Abreu,Denis Moro‐Sibilot,Christian A. Thomas,Fabrice Barlési,Gene Grant Finley,Claudia Kelsch,Anthony Lee,Shelley Coleman,Yu Deng,Yijing Shen,Marcin Kowanetz,Ariel López-Chávez,Alan Sandler,Martin Reck |
| Citations | 3,781 |
| DOI | 10.1056/nejmoa1716948 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1716948?articleTools=true |
| OpenAlex ID | https://openalex.org/W2805354595 |
| PMID | 29863955 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Denis Moro‐Sibilot](https://scholariq.org/researchers/denis-moro-sibilot/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.